Company intelligence / Profile preview

QNTM Labs

Odense, Region Syddanmark, Denmark

Ownership: Private
Employees: ~20
Development stage: Other

Overview

QNTM Labs is an active EU-GMP-licensed contract research organization (CRO) based in Odense, Denmark. Founded in 2020, it specializes in analytical testing, research, and regulatory compliance for pharmaceuticals, with a particular focus on cannabinoid-based products. The company closed a Series A funding round led by Intrinsic Capital Partners in 2022, expanded its facilities to 1,600 sq/m in 2023, and employs nearly 20 experts, aiming to innovate in lab testing.

Industry: Contract Research Organization

Partnerships

Agilent TechnologiesKnowde Group Inc.Intrinsic Capital Partners

Beyond the preview

Go deeper on QNTM Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QNTM Labs.

Explore the full profile